Literature DB >> 6119642

Dopamine receptors and schizophrenia: the neuroleptic drug problem.

G P Reynolds, P Riederer, K Jellinger, E Gabriel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119642

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  7 in total

Review 1.  The importance of dopamine D4 receptors in the action and development of antipsychotic agents.

Authors:  G P Reynolds
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

2.  3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.

Authors:  J Kornhuber; P Riederer; G P Reynolds; H Beckmann; K Jellinger; E Gabriel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study.

Authors:  G P Reynolds; J E Brown; J C McCall; A V Mackay
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  Chronic haloperidol administration increases the density of D2 dopamine receptors in the medial prefrontal cortex of the rat.

Authors:  A J MacLennan; S Atmadja; N Lee; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  [3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia.

Authors:  C Czudek; G P Reynolds
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

Authors:  Gursharan Chana; Chad A Bousman; Tammie T Money; Andrew Gibbons; Piers Gillett; Brian Dean; Ian P Everall
Journal:  Front Cell Neurosci       Date:  2013-06-26       Impact factor: 5.505

7.  Cholinergic connectivity: it's implications for psychiatric disorders.

Authors:  Elizabeth Scarr; Andrew S Gibbons; Jaclyn Neo; Madhara Udawela; Brian Dean
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.